Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity
Elizabeth E. Evans, Vikas Mishra, Crystal Mallow, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Passive immunotherapy for Alzheimer's disease
Xiaoyi Guo, Yan Li, Denghong Zhang, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102192-102192
Open Access | Times Cited: 24
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes
Xiaoyu Zhang, Chuanying Chen, Yi Liu
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
A case for seeking sex-specific treatments in Alzheimer’s disease
Marina A. Lynch
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
PLXNB1 and other signaling drives a pathologic astrocyte state contributing to cognitive decline in Alzheimer's Disease
Natacha Comandante-Lou, Tsering Lama, Kevin W. Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Exploring the therapeutic potential of Diosgenin as a Semaphorin-4D antagonist against neurodegenerative disorders
Ayushi Gupta, Princy Choudhary, Sneha Ranjan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110356-110356
Closed Access
Pepinemab: a SEMA4D antagonist for treatment of Huntington’s and other neurodegenerative diseases
Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher, et al.
Expert Opinion on Investigational Drugs (2025)
Closed Access
Emerging roles of microglia and neuroinflammation in Huntington's disease: From pathophysiology to clinical trials
Muna Abedrabbo, Pardis Kazemian, Colúm Connolly, et al.
Journal of Huntington s Disease (2025)
Closed Access
The expression of transcription factors in the human fetal subthalamic nucleus suggests its origin from the first hypothalamic prosomere
Ema Bokulić, Tila Medenica, Mihaela Bobić‐Rasonja, et al.
Brain Structure and Function (2025) Vol. 230, Iss. 2
Closed Access
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Jiangmin Chen, Shuyu Xu, Li Wang, et al.
Neuroscience (2025)
Closed Access
Decoding glioblastoma’s diversity: are neurons part of the game?
Marta Maleszewska, Adria‐Jaume Roura, Michał J. Dąbrowski, et al.
Cancer Letters (2025), pp. 217666-217666
Open Access
Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications
Leyi Huang, Wenjie Xiao, Yan Wang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 360-368
Open Access | Times Cited: 10
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Hyunju Lee, Hee-Jeong Choi, Yoo Joo Jeong, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131925-131925
Open Access | Times Cited: 2
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Jana Hroudová, Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111069-111069
Closed Access | Times Cited: 2
Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring
Paraskevi Bessa, Andrew G. Newman, Kuo Yan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Unveiling the role of astrogliosis in Alzheimer’s disease Pathology: Insights into mechanisms and therapeutic approaches
Mohit Paidlewar, Sneha Kumari, Rishika Dhapola, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112940-112940
Closed Access | Times Cited: 2
Microglia-astrocyte crosstalk is regulated by Astragalus polysaccharides mediated through suppression of Sema4D-PlexinB2 signaling in experimental autoimmune encephalomyelitis
Jinyun Ma, Qijin Lu, Yan Zhao, et al.
Brain Research (2024) Vol. 1845, pp. 149275-149275
Closed Access | Times Cited: 2
Neuroinflammatory Proteins in Huntington’s Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications
Xinhui Li, Huichun Tong, Shuying Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11787-11787
Open Access | Times Cited: 2
Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases
Maurice Zauderer, Elizabeth E. Evans
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 4
Manganese exposure leads to depressive-like behavior through disruption of the Gln Glu GABA metabolic cycle
Yujie Bi, Nannan Huang, Duo Xu, et al.
Journal of Hazardous Materials (2024), pp. 135808-135808
Closed Access | Times Cited: 1
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference
Courtney M. Kloske, Simin Mahinrad, Christopher J. Barnum, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 1
Systematic analysis of cellular crosstalk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer’s disease
Ricardo D’Oliveira Albanus, Gina M. Finan, Logan Brase, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Sema7A and Sema4D Heterodimerization is Essential for Membrane Targeting and Neocortical Wiring
Paraskevi Bessa, Andrew G. Newman, Kuo Yan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Long-read transcriptomic identification of synaptic adaptation to amyloid pathology in theAppNL-G-Fknock-in mouse model of the earliest phase of Alzheimer’s disease
Ümran Yaman, Gareth Banks, Emil K. Gustavsson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Manganese Exposure Leads to Depressive-Like Behavior Through Disruption of the Gln‒Glu‒Gaba Metabolic Cycle
Yujie Bi, Nannan Huang, Duo Xu, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top